Glucagon-like peptide 1 (GLP-1) TD Müller, B Finan, SR Bloom, D D'Alessio, DJ Drucker, PR Flatt, ... Molecular metabolism 30, 72-130, 2019 | 1177 | 2019 |
Ghrelin. Mol Metab 4: 437–460 TD Müller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ... | 1089* | 2015 |
A guide to analysis of mouse energy metabolism MH Tschöp, JR Speakman, JRS Arch, J Auwerx, JC Brüning, L Chan, ... Nature methods 9 (1), 57-63, 2012 | 799 | 2012 |
Animal models of obesity and diabetes mellitus M Kleinert, C Clemmensen, SM Hofmann, MC Moore, S Renner, ... Nature Reviews Endocrinology 14 (3), 140-162, 2018 | 794 | 2018 |
Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants A Hinney, TT Nguyen, A Scherag, S Friedel, G Brönner, TD Müller, ... PloS one 2 (12), e1361, 2007 | 655 | 2007 |
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents B Finan, B Yang, N Ottaway, DL Smiley, T Ma, C Clemmensen, ... Nature medicine 21 (1), 27-36, 2015 | 606 | 2015 |
Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans B Finan, T Ma, N Ottaway, TD Müller, KM Habegger, KM Heppner, ... Science translational medicine 5 (209), 209ra151-209ra151, 2013 | 601 | 2013 |
Anti-obesity drug discovery: advances and challenges TD Müller, M Blüher, MH Tschöp, RD DiMarchi Nature Reviews Drug Discovery 21 (3), 201-223, 2022 | 545 | 2022 |
Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups A Scherag, C Dina, A Hinney, V Vatin, S Scherag, CIG Vogel, TD Müller, ... PLoS genetics 6 (4), e1000916, 2010 | 400 | 2010 |
The new biology and pharmacology of glucagon TD Müller, B Finan, C Clemmensen, RD DiMarchi, MH Tschöp Physiological reviews 97 (2), 721-766, 2017 | 349 | 2017 |
Alternatively activated macrophages do not synthesize catecholamines or contribute to adipose tissue adaptive thermogenesis K Fischer, HH Ruiz, K Jhun, B Finan, DJ Oberlin, V Van Der Heide, ... Nature medicine 23 (5), 623-630, 2017 | 326 | 2017 |
Targeted estrogen delivery reverses the metabolic syndrome B Finan, B Yang, N Ottaway, K Stemmer, TD Müller, CX Yi, K Habegger, ... Nature medicine 18 (12), 1847-1856, 2012 | 290 | 2012 |
Gut-brain cross-talk in metabolic control C Clemmensen, TD Müller, SC Woods, HR Berthoud, RJ Seeley, ... Cell 168 (5), 758-774, 2017 | 276 | 2017 |
The role of leptin in anorexia nervosa: clinical implications J Hebebrand, TD Muller, K Holtkamp, B Herpertz-Dahlmann Molecular psychiatry 12 (1), 23-35, 2007 | 250 | 2007 |
Fibroblast growth factor 21 mediates specific glucagon actions KM Habegger, K Stemmer, C Cheng, TD Müller, KM Heppner, N Ottaway, ... Diabetes 62 (5), 1453-1463, 2013 | 246 | 2013 |
Unimolecular polypharmacy for treatment of diabetes and obesity MH Tschöp, B Finan, C Clemmensen, V Gelfanov, D Perez-Tilve, ... Cell metabolism 24 (1), 51-62, 2016 | 229 | 2016 |
Ghrelin regulation of glucose metabolism AL Poher, MH Tschöp, TD Müller Peptides 100, 236-242, 2018 | 215 | 2018 |
Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease L Niu, PE Geyer, NJ Wewer Albrechtsen, LL Gluud, A Santos, S Doll, ... Molecular systems biology 15 (3), e8793, 2019 | 212 | 2019 |
Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease B Finan, C Clemmensen, Z Zhu, K Stemmer, K Gauthier, L Müller, ... Cell 167 (3), 843-857. e14, 2016 | 182 | 2016 |
Restoration of leptin responsiveness in diet‐induced obese mice using an optimized leptin analog in combination with exendin‐4 or FGF21 TD Müller, LM Sullivan, K Habegger, CX Yi, D Kabra, E Grant, N Ottaway, ... Journal of Peptide Science 18 (6), 383-393, 2012 | 170 | 2012 |